What does VRBPAC stand for?

Vaccines and Related Biological Products Advisory Committee

This definition appears very rarely and is found in the following Acronym Finder categories:

Military and Government
Science, medicine, engineering, etc.

Other Resources:

<< Previous	Abbreviation Database Surfer		Next >>
Virtual Reality Battery Command Post Violet Red Bile Dextrose Agar Voter Registration/Ballot Delivery Volumetric Rate of the Blood Flow Violet Red Bile Glucose (agar) Variable Virtual Reality Baseball League Virtual Reality Behavior Language Vancouver Romanian Business Network (New Westminster, BC) Vacation Rentals by Owner		Virtual Reality Behavior System Video Ring Back Tone Virtual Reality-Based Technology (dentistry) Virtual Remote Batch Terminal (computing) Fleet Logistics Support Squadron (US Navy designation for naval aviation transport unit) Fleet Tactical Support Squadron (US Navy aviation unit designation used from 1960 to 1976) Vaccine Research Center (National Institutes of Health) Validation Review Committee Valley Resource Center (California) Valley Running Club

Samples in periodicals archive:

A panel of 11 experts who sit on the Vaccines and Related Biological Products Advisory Committee failed the seasonal flu vaccine that Protein Sciences produces using caterpillar cells, saying they wanted more evidence that the vaccine was safe and expressing concerns about its efficacy in the over-50 age group.

US company could make flu vaccine abroad after snub

Food and Drug Administration's (FDA's) Vaccines and Related Biological Products Advisory Committee recommended that the 2002-2003 TIIV contain A/New Caledonia/20/99-1ike (H1N1), A/Moscow/10/99-1ike (H3N2), and B/Hong Kong/ 330/01-like viruses.

Prevention and control of influenza

Professor Apicella is a member of the Vaccines and Related Biological Products Advisory Committee of the Food and Drug Administration (FDA).

ID Biomedical - Prominent Scientists Join Scientific Advisory Board

After discussions with representatives of the FDA following the October 29, 1996 meeting of the FDA's Vaccines and Related Biological Products Advisory Committee ("Advisory Committee") at which the clinical data for CERTIVA(TM) was reviewed, the Company reaffirms its previously announced assessment, as summarized below, of the views expressed by the various members of the Advisory Committee.

North American Vaccine Announces Update On FDA Advisory Committee ...